Should Medicare reimbursement for carotid artery stenting be extended to standard and low risk symptomatic and asymptomatic patients with carotid stenosis?

MeSH terms

• Angioplasty / adverse effects
• Angioplasty / economics*
• Angioplasty / instrumentation
• Asymptomatic Diseases
• Carotid Stenosis / diagnosis
• Carotid Stenosis / economics*
• Carotid Stenosis / therapy*
• Evidence-Based Medicine / economics
• Health Care Costs*
• Humans
• Insurance, Health, Reimbursement*
• Medicare / economics*
• Patient Selection
• Risk Assessment
• Risk Factors
• Severity of Illness Index
• Stents / economics*
• United States